CELL-MEDIATED IMMUNITY AND IMMUNOSUPPRESSIVE THERAPY IN HBsAg-POSITIVE CHRONIC ACTIVE HEPATITIS
โ Scribed by Pastore, G.; Dentico, P.; Buongiorno, R.; Angarano, G.; Schiraldi, O.; Tursi, A.; Loria, M.P.
- Book ID
- 123502775
- Publisher
- The Lancet
- Year
- 1979
- Tongue
- English
- Weight
- 309 KB
- Volume
- 313
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Two hundred and four patients with biopsy-proven HBsAg-positive chronic active hepatitis were treated for at least 2 years with azathioprine, prednisolone or a combination of both, or were untreated. Prevalences of HBeAg, anti-HBe, and anti-HBc were 26, 58, and loo%, respectively. Criteria for impro
Employing the techniques of complement-fixation (CF), immunofluorescence (IF), and in vitro lymphocyte transformation (LTF), the humoral antibody response and cell-mediated immune (CMI) response to cytomegalovirus (CMV) were studied in the serum and peripheral blood lymphocytes in 19 normal children
## Eleven patients of Chinese origin experienced spontaneous reactivation of chronic active hepatitis B. Eight HBsAg-positive patients were followed for an average of 15 months prior to, while three others presented during reactivation. Fatigue, hepatomegaly and jaundice were frequent findings. El